Literature DB >> 15883967

The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort.

Simona Bo1, Luigi Gentile, Giovannino Ciccone, Carla Baldi, Lorenzo Benini, Ferruccio Dusio, Claudio Lucia, Giuseppe Forastiere, Claudio Nuti, Maurizio Cassader, Gian Franco Pagano.   

Abstract

BACKGROUND: To evaluate the prevalence of the metabolic syndrome (MS) and its components in a population-based cohort, and to analyse the association between gender, environmental conditions, C-reactive protein (CRP), and the syndrome.
METHODS: Out of 1877 subjects aged 45-64, who represented all the patients of six family physicians, representative of the sanitary districts of Asti (north-western Italy), 88% accepted to participate in an interview on personal habits, and several clinical and laboratory measurements.
RESULTS: The MS (National Cholesterol Education Program criteria) was present in 24% of males and 22% of females. Males had a significantly higher percentage of hyperglycaemia, hypertension, hypertriglyceridemia, whereas females had a higher prevalence of central obesity and low HDL-cholesterol. In a multiple logistic regression model, the MS was significantly associated with increasing age, BMI, and >30 g/day alcohol intake (OR = 1.42; 95% CI 1.27-1.58), and negatively to higher education level (OR = 0.52; 95% CI 0.28-0.99) and moderate exercise (OR = 0.65; 95% CI 0.57-0.76). CRP levels are highly correlated to BMI and the components of the syndrome. The association between CRP and the MS remains significant in women only, in a multivariate analysis, after multiple adjustments (OR = 1.73; 95% CI 1.42-2.11). Higher CRP levels, correlated to smoking and, inversely, to alcohol intake, identify a further 12% of the cohort at higher cardiovascular risk.
CONCLUSIONS: The MS affects more than 20% of this middle-aged cohort, but more than 30%, with higher CRP levels are at high cardiovascular risk. Healthier lifestyle habits are inversely associated with the MS and CRP levels, suggesting the need for strategies and their implementation in the general population. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883967     DOI: 10.1002/dmrr.561

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  19 in total

1.  Long lasting effects of smoking: breast cancer survivors' inflammatory responses to acute stress differ by smoking history.

Authors:  Jeanette M Bennett; Ronald Glaser; Rebecca R Andridge; Juan Peng; William B Malarkey; Janice K Kiecolt-Glaser
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

2.  Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors:  Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal:  Brain Behav Immun       Date:  2018-06-19       Impact factor: 7.217

3.  C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study.

Authors:  Tsan Yang; Chi-Hong Chu; Po-Chien Hsieh; Chih-Hsung Hsu; Yu-Ching Chou; Shih-Hsien Yang; Chyi-Huey Bai; San-Lin You; Lee-Ching Hwang; Tieh-Chi Chung; Chien-An Sun
Journal:  Endocrine       Date:  2012-07-19       Impact factor: 3.633

4.  Review: Metabolic Syndrome in Black South African Women.

Authors:  Philippe Jean-Luc Gradidge; Nigel J Crowther
Journal:  Ethn Dis       Date:  2017-04-20       Impact factor: 1.847

5.  Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult Italian population-based cohort.

Authors:  Roberto Gambino; Simona Bo; Luigi Gentile; Giovanni Musso; Gianfranco Pagano; Paolo Cavallo-Perin; Maurizio Cassader
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 17.152

6.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

7.  Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial.

Authors:  Simona Bo; Giovannino Ciccone; Carla Baldi; Lorenzo Benini; Ferruccio Dusio; Giuseppe Forastiere; Claudio Lucia; Claudio Nuti; Marilena Durazzo; Maurizio Cassader; Luigi Gentile; Gianfranco Pagano
Journal:  J Gen Intern Med       Date:  2007-10-06       Impact factor: 5.128

8.  Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction.

Authors:  S Bo; R Gambino; M Durazzo; F Ghione; G Musso; L Gentile; M Cassader; P Cavallo-Perin; G Pagano
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

9.  PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.

Authors:  James T Willerson; Greg Cable; Edward T H Yeh
Journal:  Tex Heart Inst J       Date:  2009

10.  Role of plasma adiponectin /C-reactive protein ratio in obesity and type 2 diabetes among African Americans.

Authors:  Preetha Anna Abraham; Selasi Attipoe; Josh B Kazman; Stacey Anne Zeno; Merrily Poth; Patricia Anne Deuster
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.